|
Volumn 16, Issue 15, 2000, Pages 1471-1479
|
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD16 ANTIGEN;
CD19 ANTIGEN;
CD3 ANTIGEN;
CD34 ANTIGEN;
CD38 ANTIGEN;
CD4 ANTIGEN;
CD8 ANTIGEN;
COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;
HEMOGLOBIN;
ADULT;
BLOOD ANALYSIS;
BONE MARROW CELL;
CELL CULTURE;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
ERYTHROCYTE COUNT;
FEMALE;
HEMATOPOIESIS;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
LEUKOCYTE COUNT;
MALE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
STEM CELL;
TREATMENT OUTCOME;
VIRUS LOAD;
ADULT;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
BONE MARROW;
CELLS, CULTURED;
DNA, VIRAL;
FEMALE;
FLOW CYTOMETRY;
HEMATOLOGY;
HEMATOPOIESIS;
HIV INFECTIONS;
HIV-1;
HUMANS;
LEUKOCYTES, MONONUCLEAR;
MALE;
METHYLCELLULOSE;
MIDDLE AGED;
POLYMERASE CHAIN REACTION;
TIME FACTORS;
|
EID: 0034633612
PISSN: 08892229
EISSN: None
Source Type: Journal
DOI: 10.1089/088922200750005994 Document Type: Conference Paper |
Times cited : (43)
|
References (42)
|